mortality/aging
|
|
• females become ill and begin to die at 8 weeks of age with a median survival age of 39 weeks; however, some survive to 50 weeks of age
(J:102306)
|
renal/urinary system
|
|
• urine concentrations of protein greater than 10 mg/mg creatinine are seen in 78% of females after 9 weeks of age
(J:102306)
|
|
|
• in older, visibly ill mice, kidneys appear pale and dull and are pockmarked
(J:102306)
• the appearance of kidney abnormalities is delayed relative to hemizygous mutant males
(J:102306)
|
|
|
• abnormalities similar to those in males are seen but at later times
(J:102306)
• at 17 weeks of age some glomeruli develop focal areas of lamellation and other diffuse changes with widespread abnormalities seen at 30 weeks of age
(J:102306)
|
|
|
• abnormalities similar to those in males are seen but at later times
(J:102306)
|
pale kidney
(
J:102306
)
|
|
• in older, visibly ill mice, kidneys appear pale
(J:102306)
|
homeostasis/metabolism
|
|
(J:102306)
|
|
|
• urine concentrations of protein greater than 10 mg/mg creatinine are seen in 78% of females after 9 weeks of age
(J:102306)
|
Mouse Models of Human Disease |
OMIM ID | Ref(s) | |
| Alport Syndrome, X-Linked; ATS | 301050 | J:102306 | |
